Ischemic stroke and mitochondria: mechanisms and targets

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Stroke is a leading cause of death and disability globally.
• Current treatments for ischemic stroke, such as tissue plasminogen activator and endovascular thrombectomy, have narrow therapeutic time windows.
• There is a critical need for novel therapeutic targets to improve stroke management.

Purpose of the Study:

• To review the multifaceted roles of mitochondria in cerebral ischemia.
• To highlight mitochondrial mechanisms involved in neural cell death during ischemic stroke.
• To explore the potential of mitochondria as therapeutic targets for neurological diseases.

Main Methods:

• Literature review focusing on mitochondrial functions in cerebral ischemia.
• Analysis of studies investigating mitochondrial roles in reactive oxygen species (ROS) generation, apoptosis, and electron transport chain dysfunction.
• Synthesis of current understanding of mitochondrial involvement in neural cell death.

Main Results:

• Mitochondria are implicated in reactive oxygen species (ROS) generation during ischemia.
• Mitochondrial dysfunction contributes to apoptotic pathways in neural cells.
• Electron transport chain abnormalities are a key feature of mitochondrial involvement in stroke.

Conclusions:

• Mitochondria are central to the pathophysiology of ischemic stroke.
• Targeting mitochondrial pathways offers a promising strategy for developing new stroke therapies.
• Further research into mitochondrial mechanisms could benefit treatment of various neurological disorders.